Skip to main content
Premium Trial:

Request an Annual Quote

Compugen Posts Declining Revenue, Widened Loss in Q4

NEW YORK, Feb. 13 - Compugen on Wednesday reported that revenue shrank in the fourth quarter as a moderate increase in R&D spending conspired to widen net losses.


Total revenue in the period ended Dec. 31 fell to $3.1 million from $3.4 million one year ago as income from products and services slowed, the company said. An increase in research grants to $406,000 from $98,000 kept the top line from contracting further.


A moderate increase in R&D spending, which came to $3.5 million from $3.0 million in the year-ago period, contributed to an overall increase in expenditures for the quarter that grew to $7.8 million from $6.5 million one year ago, according to Compugen.


The Israel-based firm said that net loss in the quarter ballooned to $4.1 million, or $.16 per share, compared with $1.5 million, or $.06 per share, year over year.


Last month, Compugen launched Agro-LEADS, an ag-bio and plant genomics subsidiary designed to integrate computational biology and plant genomics with traditional agricultural techniques.


Based in Rehovot, Israel, Agro-LEADS will focus on developing seeds with improved traits. It also plans collaborations with outside researchers in crop protection, nutritionally improved crops, and the expression of therapeutic and industrial products in genetically engineered plants.


The subsidiary will be co-managed by Hagai Karchi and Rafael Meissner, who are also co-founders. Their team includes plant geneticists, bioinformaticists, molecular biologists, and traditional plant breeders.

The Scan

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.

SpliceVault Portal Provides Look at RNA Splicing Changes Linked to Genetic Variants

The portal, described in Nature Genetics, houses variant-related messenger RNA splicing insights drawn from RNA sequencing data in nearly 335,700 samples — a set known as the 300K-RNA resource.

Automated Sequencing Pipeline Appears to Allow Rapid SARS-CoV-2 Lineage Detection in Nevada Study

Researchers in the Journal of Molecular Diagnostics describe and assess a Clear Labs Dx automated workflow, sequencing, and bioinformatic analysis method for quickly identifying SARS-CoV-2 lineages.

UK Team Presents Genetic, Epigenetic Sequencing Method

Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers.